Brief Article
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Oct 28, 2009; 15(40): 5091-5096
Published online Oct 28, 2009. doi: 10.3748/wjg.15.5091
Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor
Kemal Karakaya, Volkan Hanci, Sibel Bektas, Murat Can, Hamdi B Ucan, Ali Ugur Emre, Oge Tascılar, Isıl Ozkocak Turan, Mustafa Comert, Oktay Irkorucu, Guldeniz Karadeniz Cakmak
Kemal Karakaya, Hamdi B Ucan, Ali Ugur Emre, Oge Tascılar, Mustafa Comert, Oktay Irkorucu, Guldeniz Karadeniz Cakmak, Department of General Surgery, Zonguldak Karaelmas University, Medical Faculty, 67600 Kozlu, Zonguldak, Turkey
Volkan Hanci, Isıl Ozkocak Turan, Department of Anesthesiology, Zonguldak Karaelmas University, Medical Faculty, 67600 Kozlu, Zonguldak, Turkey
Sibel Bektas, Department of Pathology, Zonguldak Karaelmas University, Medical Faculty, 67600 Kozlu, Zonguldak, Turkey
Murat Can, Department of Biochemistry, Zonguldak Karaelmas University, Medical Faculty, 67600 Kozlu, Zonguldak, Turkey
Author contributions: Karakaya K and Hanci V designed the research; Karakaya K, Hanci V, Bektas S and Can M performed the research; Karakaya K, Hanci V, Ucan HB, Tascılar O, Can M, Emre AU, Irkorucu O, and Karadeniz Cakmak G analyzed the data; Karakaya K, Can M, Hanci V wrote the paper; Ozkocak Turan I and Comert M critically revised the manuscript for important intellectual content.
Correspondence to: Kemal Karakaya, MD, Assistant Professor of Surgery, Department of General Surgery, Zonguldak Karaelmas University, Medical Faculty, 67600 Kozlu, Zonguldak, Turkey. karakayakemal@hotmail.com
Telephone: +90-532-6946400 Fax: +90-372-2610155
Received: June 15, 2009
Revised: August 4, 2009
Accepted: August 11, 2009
Published online: October 28, 2009
Core Tip